These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11239171)

  • 1. The molecular perspective: targeted toxins.
    Goodsell DS
    Stem Cells; 2001; 19(2):161-2. PubMed ID: 11239171
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral infection permeabilizes mammalian cells to protein toxins.
    Fernández-Puentes C; Carrasco L
    Cell; 1980 Jul; 20(3):769-75. PubMed ID: 6251972
    [No Abstract]   [Full Text] [Related]  

  • 3. The history of ricin, abrin and related toxins.
    Olsnes S
    Toxicon; 2004 Sep; 44(4):361-70. PubMed ID: 15302520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon nanotubes as a protein toxin transporter for selective HER2-positive breast cancer cell destruction.
    Weng X; Wang M; Ge J; Yu S; Liu B; Zhong J; Kong J
    Mol Biosyst; 2009 Oct; 5(10):1224-31. PubMed ID: 19756312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the functional dyad of animal toxins acting on voltage-gated Kv1-type channels.
    Mouhat S; De Waard M; Sabatier JM
    J Pept Sci; 2005 Feb; 11(2):65-8. PubMed ID: 15635666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural-functional studies of animal toxins.
    Fontes MR
    Protein Pept Lett; 2009; 16(8):851. PubMed ID: 19689410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
    Gabius S; Gabius HJ
    Dtsch Med Wochenschr; 2002 Mar; 127(9):457-9. PubMed ID: 11870561
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular perspective: targeted toxins.
    Goodsell DS
    Oncologist; 2001; 6(1):110-1. PubMed ID: 11161234
    [No Abstract]   [Full Text] [Related]  

  • 9. How do toxins penetrate cells?
    Hughes RC
    Nature; 1979 Oct; 281(5732):526-7. PubMed ID: 492314
    [No Abstract]   [Full Text] [Related]  

  • 10. Microtiter-based assay for evaluating the biological activity of ribosome-inactivating proteins.
    Hale ML
    Pharmacol Toxicol; 2001 May; 88(5):255-60. PubMed ID: 11393586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RelBE or not to be.
    Wilson DN; Nierhaus KH
    Nat Struct Mol Biol; 2005 Apr; 12(4):282-4. PubMed ID: 15809644
    [No Abstract]   [Full Text] [Related]  

  • 12. The integrity of the sarcin/ricin domain of 23 S ribosomal RNA is not required for elongation factor-independent peptide synthesis.
    Chan YL; Wool IG
    J Mol Biol; 2008 Apr; 378(1):12-9. PubMed ID: 18342885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.
    Holbourn KP; Shone CC; Acharya KR
    FEBS J; 2006 Oct; 273(20):4579-93. PubMed ID: 16956368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the knowledge of animal toxins to generate drugs.
    Zambelli VO; Pasqualoto KF; Picolo G; Chudzinski-Tavassi AM; Cury Y
    Pharmacol Res; 2016 Oct; 112():30-36. PubMed ID: 26826284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitoxins: novel strategies to target agents of bioterrorism.
    Rainey GJ; Young JA
    Nat Rev Microbiol; 2004 Sep; 2(9):721-6. PubMed ID: 15372082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saporin and ricin A chain follow different intracellular routes to enter the cytosol of intoxicated cells.
    Vago R; Marsden CJ; Lord JM; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
    FEBS J; 2005 Oct; 272(19):4983-95. PubMed ID: 16176271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical aspects of toxin weapons.
    Bigalke H; Rummel A
    Toxicology; 2005 Oct; 214(3):210-20. PubMed ID: 16087285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U; Göthel D; Leng-Peschlow E
    Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF; Audia PF
    Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ricin A chain and ricin A chain-KDEL in Escherichia coli.
    Zhan J; Chen Y; Wang K; Zheng S
    Protein Expr Purif; 2004 Apr; 34(2):197-201. PubMed ID: 15003251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.